These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4066510)

  • 1. Synthesis of 3'-deoxy-3'-fluorokanamycins A and B active against resistant bacteria.
    Tsuchiya T; Takahashi Y; Kobayashi Y; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1287-90. PubMed ID: 4066510
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 4'-deoxy-4'-fluorokanamycin A and B.
    Takahashi Y; Tsuneda S; Tsuchiya T; Koyama Y; Umezawa S
    Carbohydr Res; 1992 Jul; 232(1):89-105. PubMed ID: 1423353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214).
    Richardson K; Brammer KW; Jevons S; Plews RM; Wright JR
    J Antibiot (Tokyo); 1979 Oct; 32(10):973-7. PubMed ID: 528375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 3',4'-dideoxy and 3',4',5''-trideoxyribostamycin active against kanamycin-resistant E. coli and P. aeruginosa.
    Umezawa S; Tsuchiya T; Ikeda D; Umezawa H
    J Antibiot (Tokyo); 1972 Oct; 25(10):613-6. PubMed ID: 4630694
    [No Abstract]   [Full Text] [Related]  

  • 8. Syntheses and properties of the 6"-deoxy or 4",6"-dideoxy derivatives of the kanamycin antibiotics.
    Miyasaka T; Ikeda D; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1980 May; 33(5):527-32. PubMed ID: 7429979
    [No Abstract]   [Full Text] [Related]  

  • 9. Aminoglycoside antibiotics. XII. Effect of N-alkylation in kanamycin antibiotics.
    Nakagawa S; Toda S; Abe Y; Yamashita H; Fujisawa KI; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1978 Jul; 31(7):675-80. PubMed ID: 690002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning the regioselectivity of the Staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification.
    Li J; Chen HN; Chang H; Wang J; Chang CW
    Org Lett; 2005 Jul; 7(14):3061-4. PubMed ID: 15987205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
    Fosso MY; Shrestha SK; Green KD; Garneau-Tsodikova S
    J Med Chem; 2015 Dec; 58(23):9124-32. PubMed ID: 26592740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 3'-deoxy-3'-fluorokanamycin A and 3',4'-dideoxy-3'-fluorokanamycin A.
    Takahashi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1991 Mar; 210():221-32. PubMed ID: 1878879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and antibacterial activities of conformationally constrained kanamycin A derivatives.
    Zhang W; Chen Y; Liang Q; Li H; Jin H; Zhang L; Meng X; Li Z
    J Org Chem; 2013 Jan; 78(2):400-9. PubMed ID: 23228010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.
    Kondo S; Iinuma K; Yamamoto H; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1973 Jul; 26(7):412-5. PubMed ID: 4782059
    [No Abstract]   [Full Text] [Related]  

  • 15. Deoxygenation of aminoglycosides.
    Tsuchiya T
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S129-35. PubMed ID: 398898
    [No Abstract]   [Full Text] [Related]  

  • 16. Aminoglycoside antibiotics. 5. Regiospecific synthesis of 1-N-[(S)-4-amino-2-hydroxybutyryl]-2"-deoxykanamycin B from neamine.
    Sharma MN; Kumar V; Remers WA
    J Antibiot (Tokyo); 1982 Jul; 35(7):905-10. PubMed ID: 7174540
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B.
    Kumar V; Jones GS; Blacksberg I; Remers WA; Misiek M; Pursiano TA
    J Med Chem; 1980 Jan; 23(1):42-9. PubMed ID: 6244410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective modification of the 3''-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains.
    Santana AG; Zárate SG; Asensio JL; Revuelta J; Bastida A
    Org Biomol Chem; 2016 Jan; 14(2):516-525. PubMed ID: 26501183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses of 6'-N-methyl-kanamycin and 3',4'-dideoxy-6'-N-methylkanamycin B active against resistant strains having 6'-N-acetylating enzymes.
    Umezawa H; Nishimura Y; Tsuchiya T; Umezawa S
    J Antibiot (Tokyo); 1972 Dec; 25(12):743-5. PubMed ID: 4651829
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents.
    Bera S; Zhanel GG; Schweizer F
    Bioorg Med Chem Lett; 2010 May; 20(10):3031-5. PubMed ID: 20413307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.